Clene

CLNNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$62.257 M

$4.38 -3.52%

Close of 22 Sept 2026

Revenue

$200.0K

#3571 by revenue

Earnings

-$26.2M

Loss-making

Shares outstanding

12,848,513

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#340Stablecoin DevelopmentSDEV$64.3M
#341IntercureINCR$63.8M
#342CleneCLNN$62.3M
#343Hyperion DefiHYPD$62.0M
#344Nomad Power SolutionsNMAD$61.5M

What if Clene were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,127,059

Per share 485,630× higher

Bitcoin $1.74T

$122,531.12

Per share 27,975× higher

Nvidia $5.52T

$388,052.23

Per share 88,596× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Clene are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.